ETR:HNL

Dr. Hönle (HNL) Stock Forecast, Price & News

€23.00

+1.30 (+5.99%)

(As of 05/18/2022 12:00 AM ET)

Add

Compare

Today's Range: €22.45
▼
€23.00
50-Day Range: €21.70
▼
€33.40
52-Week Range: €22.65
▼
€53.80

Volume: 7,190 shs
Average Volume: N/A
Market Capitalization: $139.42 million

P/E Ratio: N/A
Dividend Yield: 0.86%
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive HNL News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Hönle and its competitors with MarketBeat's FREE daily newsletter.

About Dr. Hönle

Dr. Hönle AG supplies industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, medical technology, optics and opto electronics, automotive, and glass processing. The Equipment & Systems segment engages in the drying of inks and coatings, curing of adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange: ETR
Industry: Electronic Components
Sub-Industry: N/A
Sector: Computer and Technology
Current Symbol: ETR:HNL
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.hoenle.de
Phone: 49 89 85608 0
Fax: N/A
Employees: 657
Year Founded: N/A

Sales & Book Value

Annual Sales: $121.98 million
Price / Sales: 1.14
Cash Flow: €1.20 per share
Price / Cash Flow: 19.23
Book Value: €18.90 per share
Price / Book: 1.22

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 47.61
Current Ratio: 3.05
Quick Ratio: 1.08

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: 9.96
P/E Growth: 0.38

Miscellaneous

Outstanding Shares: 6,061,850
Free Float: N/A
Market Cap: $139.42 million
Optionable: Not Optionable

Company Calendar

Today: 5/19/2022
Next Earnings (Estimated): 8/05/2022

MarketRank^™

Overall MarketRank^™

1.50 out of 5 stars

2.0 Analyst's Opinion

Price Target Upside/Downside
According to analysts' consensus price target of €63.00, Dr. Hönle has a forecasted upside of 173.9% from its current price of €23.00.
Amount of Analyst Coverage
Dr. Hönle has received no research coverage in the past 90 days.

4.3 Community Rank

Outperform Votes
Dr. Hönle has received 19 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Dr. Hönle has received 11 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Dr. Hönle has received 63.33% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Dr. Hönle and other stocks. Vote “Outperform” if you believe HNL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HNL will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Dr. Hönle has a dividend yield of 0.86%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Dr. Hönle does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Dr. Hönle insiders have not sold or bought any company stock.

1.3 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Dr. Hönle is -42.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Dr. Hönle is -42.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Dr. Hönle has a PEG Ratio of 0.38. PEG Ratios below 1 indicate that a company could be undervalued.
Price to Book Value per Share Ratio
Dr. Hönle has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Dr. Hönle (ETR:HNL) Frequently Asked Questions

Is Dr. Hönle a buy right now?: 0 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dr. Hönle in the last twelve months. There are currently for the stock. The consensus among Wall Street research analysts is that investors should "n/a" Dr. Hönle stock.
View analyst ratings for Dr. Hönle or view top-rated stocks.
When is Dr. Hönle's next earnings date?: Dr. Hönle is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022.
View our earnings forecast for Dr. Hönle.
Is Dr. Hönle a good dividend stock?: Dr. Hönle pays an annual dividend of €0.20 per share and currently has a dividend yield of 0.86%.
What price target have analysts set for HNL?: 0 Wall Street analysts have issued 12-month target prices for Dr. Hönle's shares. Their forecasts range from €62.00 to €64.00. On average, they expect Dr. Hönle's share price to reach €63.00 in the next twelve months. This suggests a possible upside of 173.9% from the stock's current price.
View analysts' price targets for Dr. Hönle or view top-rated stocks among Wall Street analysts.
Who are Dr. Hönle's key executives?: Dr. Hönle's management team includes the following people:
Dr. Norbert Haimerl M.B.A., CFO, MD of Investor Relations, Logistics & Quality Management and Member of Management Board (Age 60, Pay $697k)
Mr. Heiko Runge Grad. Eng., MD of Sales & Marketing and Member of Management Board (Age 58, Pay $662k)
Mr. Rainer Pumpe, MD of Devel. & Production and Member of the Management Board (Age 54, Pay $331.94k)
Peter Weinert, Head of Investor Relations
Who are some of Dr. Hönle's key competitors?: Some companies that are related to Dr. Hönle include FW Thorpe (TFW), Strix Group (KETL), Gooch & Housego (GHH), Luceco (LUCE), Xaar (XAR), Hammond Power Solutions (HPS.A), Electrovaya (EFL), Ilika (IKA), EEStor Co. (ESU.V) (ESU), NexOptic Technology (NXO), Trackwise Designs (TWD), Light Science Technologies (LST), CAP-XX (CPX), Smartcool Systems Inc. (SSC.V) (SSC) and ProPhotonix (PPIX).
View all of HNL's competitors.
What is Dr. Hönle's stock symbol?: Dr. Hönle trades on the ETR under the ticker symbol "HNL."
What is Dr. Hönle's stock price today?: One share of HNL stock can currently be purchased for approximately €23.00.
How much money does Dr. Hönle make?: Dr. Hönle has a market capitalization of $139.42 million and generates $121.98 million in revenue each year.
How many employees does Dr. Hönle have?: Dr. Hönle employs 657 workers across the globe.
What is Dr. Hönle's official website?: The official website for Dr. Hönle is www.hoenle.de.
How can I contact Dr. Hönle?: The company can be reached via phone at 49 89 85608 0.

This page was last updated on 5/19/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.